SynthesisThe Lancet. Oncology2014

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials.

Robert K Hills et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.